In contrast to industry stakeholders, I work at a non-profit Sloan Kettering and when a clinician or nurse comes up with an invention-a new car-T cell therapy, or robotic surgical instrument they disclose their invention to our office (Office of Technology Development) and we work to protect the intellectual property (IP) and develop the inventions that are commercially viable and license them to larger device companies or create a start-up. The stakeholders of a the development of a Sloan Kettering medical device include: inventor(s) (we call them PIs for principal investigators), VP of Technology Development, the President of the department, Research and Technology Management, patients (end customer) and for start-ups and large value technologies, investors, our board members and CEO and President, Craig Thompson. Overall there are a lot of key stakeholders for developing a commercially viable medical device at Sloan.